Geron Corporation (GERN)
NASDAQ: GERN · Real-Time Price · USD
2.960
+0.070 (2.42%)
At close: Jan 21, 2025, 4:00 PM
2.940
-0.020 (-0.68%)
After-hours: Jan 21, 2025, 7:54 PM EST
Geron Employees
Geron had 141 employees as of December 31, 2023. The number of employees increased by 34 or 31.78% compared to the previous year.
Employees
141
Change (1Y)
34
Growth (1Y)
31.78%
Revenue / Employee
$209,078
Profits / Employee
-$1,426,901
Market Cap
1.79B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
GERN News
- 10 hours ago - Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 5 days ago - Geron: Positive IMpactMF Trial Could Possibly Lead To Doubling Of RYTELO Sales - Seeking Alpha
- 5 weeks ago - Geron Announces Positive CHMP Opinion for RYTELO™ (imetelstat) for the Treatment of Adults with Transfusion-Dependent Anemia due to Lower-Risk MDS - Business Wire
- 6 weeks ago - Geron Announces New IMerge Analyses Presented at ASH Suggesting Clinical Activity of RYTELO™ (imetelstat) in Patients with Lower-Risk MDS Regardless of Type or Number of Prior Therapies - Business Wire
- 6 weeks ago - Geron Announces Phase 1 Findings from Two-Part IMproveMF Study Presented at ASH Suggesting Tolerability of RYTELO™ (imetelstat) in Combination with Ruxolitinib as Frontline Therapy in Patients with Myelofibrosis - Business Wire
- 7 weeks ago - Geron to Participate in the 7th Annual Evercore ISI HealthCONx Conference - Business Wire
- 2 months ago - Geron: A Strong Launch And Financial Deals Make It Attractive - Seeking Alpha
- 2 months ago - Geron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development - Business Wire